Eyes on Systems Pharmacology – Development of a Disease-Modifying Therapy for Retinal Degenerations

Bidragets beskrivning

Retinal degenerative diseases are blinding conditions that generally lack preventive therapies. Particularly Age-related Macular Degeneration is a major healthcare burden. A treatment that would slow degeneration regardless of the underlying pathology could lead to satisfactory resolution fastest, especially if based on clinical drugs approved for use in other indications. I have spent several years in the USA working on a combinational drug treatment concept that capitalizes on drug repurposing. We have shown that the treatment is effective against retinal degeneration in many disease models. My intent is to continue this research in Finland. Specifically, I start working towards intraocularly administered therapy to minimize drug side effects. My aim is to develop the first clinical treatment to slow progression of retinal degeneration. The use of multiple cooperating drugs, repurposing and local administration in a single regimen would become an unprecedented medical advancement.
Visa mer

Startår

2021

Slutår

2026

Beviljade finansiering

Henri Leinonen Orcid -palvelun logo
447 650 €

Andra beslut

361972
Akademiforskarens forskningskostnader(2024)
200 000 €
346295
Akademiforskarens forskningskostnader(2021)
300 000 €

Finansiär

Finlands Akademi

Typ av finansiering

Akademiforskare

Övriga uppgifter

Finansieringsbeslutets nummer

339691

Vetenskapsområden

Farmaci

Forskningsområden

Farmasia

Identifierade teman

eyes, eye diseases